THE ROLE OF NHS ENGLAND COMMISSIONING POLICIES IN PROMOTING EQUITABLE ACCESS TO HIGH-COST DRUGS

被引：0
|
作者：
Anderson, Marina [1 ]
机构：
[1] Univ Liverpool, Univ Hosp Aintree, Dept Rheumatol, Liverpool L69 3BX, Merseyside, England
来源：
RHEUMATOLOGY | 2015年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I69
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [11] Doing evidence-based medicine? How NHS managers ration high-cost drugs
    Hughes, David
    Doheny, Shane
    SOCIAL SCIENCE & MEDICINE, 2019, 235
  • [12] GLOBAL TRENDS IN ALTERNATIVE ACCESS ARRANGEMENTS FOR HIGH-COST ONCOLOGY AND RARE DISEASE DRUGS
    Nash, C.
    Kunitskaya, A.
    Duttagupta, S.
    VALUE IN HEALTH, 2020, 23 : S252 - S252
  • [13] Financing Strategies to Facilitate Access to High-Cost Anticancer Drugs: A Systematic Review of the Literature
    Patikorn, Chanthawat
    Taychakhoonavudh, Suthira
    Sakulbumrungsil, Rungpetch
    Ross-Degnan, Dennis
    Anantachoti, Puree
    INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2022, 11 (09) : 1625 - 1634
  • [14] STRATEGIES TO IMPROVE ACCESS TO HIGH-COST ANTICANCER DRUGS: LESSONS LEARNED FOR ASEAN COUNTRIES
    Patikorn, C.
    Taychakhoonavudh, S.
    Anantachoti, P.
    VALUE IN HEALTH, 2018, 21 : S20 - S21
  • [15] Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab
    Barrios, Carlos Henrique
    Reinert, Tomas
    Werutsky, Gustavo
    ECANCERMEDICALSCIENCE, 2019, 13
  • [16] Patents Associated with High-Cost Drugs in Australia
    Christie, Andrew F.
    Dent, Chris
    McIntyre, Peter
    Wilson, Lachlan
    Studdert, David M.
    PLOS ONE, 2013, 8 (04):
  • [17] Evolution of consumption of high-cost drugs in Colombia
    Machado Alba, Jorge Enrique
    Moncada Escobar, Juan Carlos
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2012, 31 (04): : 283 - 289
  • [18] HIGH-COST ONCOLOGY DRUGS IN BRAZIL AND MEXICO: ACCESS DIFFERENCES BETWEEN THE PUBLIC AND PRIVATE SETTINGS
    Anilines, Giao N. T.
    Ribeiro, A.
    Duval, A.
    Moore, R.
    VALUE IN HEALTH, 2017, 20 (09) : A879 - A879
  • [19] Patient access schemes for high-cost cancer medicines
    Williamson, Steve
    LANCET ONCOLOGY, 2010, 11 (02): : 111 - 112
  • [20] CLINICAL AND ETHICAL PERSPECTIVES ON RATIONING OF HIGH-COST DRUGS
    POIRIER, TI
    GIANNETTI, VJ
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (01) : 78 - 81
12345